On February 17, 2026, MIG Capital reported a significant sell-off in its shares of Sotera Health (NASDAQ:SHC), unloading 2,262,292 shares worth approximately $37.41 million. This move reflects a normal adjustment in their investment strategy rather than a loss of confidence in Sotera.
Despite this sale, Sotera remains an important part of MIG’s portfolio, accounting for about 5.88% of their assets under management. As of the last trading session, Sotera Health’s shares were priced at $13.41, showing an 18% increase over the past year, slightly trailing the S&P 500’s 20% growth during the same time frame.
Financial Snapshot
- Market Cap: $3.8 billion
- Revenue (TTM): $1.16 billion
- Net Income (TTM): $77.95 million
Sotera specializes in sterilization services for medical devices, pharmaceuticals, and food safety. They operate in highly regulated industries and have managed to maintain strong profitability. The company recently celebrated its 20th consecutive year of revenue growth, with a 5.7% increase in sales in 2025. Adjusted EBITDA also rose 8.2%, indicating robust operational efficiency.
Industry Insights
Experts predict the sterilization market will grow significantly in the coming years. According to a recent report by Grand View Research, the global sterilization services market is expected to reach $6.94 billion by 2027, growing at a CAGR of 11.5%. Companies like Sotera are well-positioned to take advantage of this trend, given their expertise and established networks.
Investor Takeaway
Even with MIG Capital trimming its stake, it’s vital to consider the long-term potential of Sotera Health. The company is projecting revenue growth of 5% to 6.5% for 2026, along with an increase in adjusted EBITDA. Therefore, for those watching Sotera, the fundamentals suggest a solid future.
Recent user discussions on social media highlight mixed sentiments about the stock. While some investors express caution due to the recent sell-off, many are optimistic given the company’s solid financial track record and its critical role in healthcare.
For more details on ongoing SEC filings and financial health, check the SEC’s official resources or visit Sotera’s investor relations page.
Source link
Sotera Health, assets under management, MIG Capital, pharmaceutical companies
